GFT's Q1 26 came in bang in line with our expectations.
Raute’s low order book remains an issue for now, but in our view chances are European orders will be...
Redeye comments on Fractal's Q1 2026 report, a quarter shaped entirely by an industry-wide shortage ...
Investors House's Q1 report was burdened by one-off costs, and both the Real Estate and Services seg...
Suominen's Q1 comparable EBITDA fell short of Vara Research consensus expectations.
Q1 net sales and adjusted EBITDA were slightly below our expectations.
Duell announced on Thursday that it is appointing Tomi Virtanen as CEO.
* Strong margins (19% adj. EBIT margin), improved ACV * We raise '26e/'27e/'28e EBIT by 20%/6%/5% on...
Bra rapport från Railcare där Entreprenad överraskar positivt och väger upp ett tillfälligt svagare ...
Premium Snacks levererade ett starkt Q1’26 med en tillväxt om 17,9 % och förbättrad lönsamhet, trots...
Redeye returns with an update following AlzeCure’s Q1 earnings release.
Redeye comments on Active Biotech's first quarter report.
Redeye considers GomSpace’s Q1 trading update to be healthy, showing continued progress with figures...
LAIQON’s first Q1 26 KPI release on 27 April showed continued AuM momentum, while profitability remained below our expectations.
Redeye updates its estimates and valuation after Boreo’s Q1 2026 report.
Tradedoubler reported Q126 results that showed continued strong revenue growth from Influencer Marke...
Redeye provides its initial take on Navigo’s Q1 2026 report, which came in slightly below our sales ...
Suominen’s Q1 figures were lower than estimated yet the company retains its guidance for improving F...
* Big deviations in a seasonally smaller quarter * Strong orders de-risks '26e in our view * Estimat...
* Sales +27% vs. ABGSCe, EBIT SEK 19m vs. ABGSCe 9.
Suominen Q1 comparable EBITDA of EUR 2.2m came 33% below Vara Research consensus expectations.
Redeye comments on W5 Solutions Q1-results which were better than expected, driven by solid topline ...
